Journal of Clinical Endocrinology & Metabolism, Vol 79, 1470-1475, Copyright © 1994 by Endocrine Society

ARTICLES

Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure

LM Nelson, JN Anasti, LM Kimzey, RA Defensor, KJ Lipetz, BJ White, TH Shawker and MJ Merino
Section on Gynecologic Research, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

Despite having amenorrhea and markedly elevated serum gonadotropin levels, some women with karyotypically normal spontaneous premature ovarian failure, nevertheless, have ovarian follicles that function intermittently. Graafian follicles capable of responding to these high FSH levels are faced with high serum LH levels as well, which might induce inappropriate luteinization and prevent normal follicle function. We examined this possibility using weekly blood sampling and sonography in 65 patients. Nearly 50% of our patients demonstrated ovarian follicle function [serum estradiol, > 183 pmol/L (50 pg/mL)] during a median of 4 months of observation (range, 2-6 months). However, during this observation, only 16% achieved an ovulatory serum progesterone level [> 9.5 nmol/L (3.0 ng/mL)]. We imaged an antral follicle by sonography in over 40% of patients (27 of 65), and serum estradiol was significantly greater when an antral follicle was present. The follicles in these patients were not functioning normally, however. In contrast to normal women, patients with ovarian failure had poor correlation between follicle diameter and serum estradiol. We biopsied these antral follicles in 6 patients and found luteinized Graafian follicles in all cases. Therefore, luteinized Graafian follicles account for at least 60% of the antral structures imaged (95% confidence limit). Thus, inappropriate luteinization of Graafian follicles appears to be a major pathophysiological mechanism in patients with karyotypically normal spontaneous premature ovarian failure.

This article has been cited by other articles:

				G. Meduri, N. Massin, J. Guibourdenche, A. Bachelot, O. Fiori, F. Kuttenn, M. Misrahi, and P. Touraine Serum anti-Mullerian hormone expression in women with premature ovarian failure Hum. Reprod., January 1, 2007; 22(1): 117 - 123. [Abstract] [Full Text] [PDF]

				K Raile, H Stobbe, R B Trobs, W Kiess, and R Pfaffle A new heterozygous mutation of the FOXL2 gene is associated with a large ovarian cyst and ovarian dysfunction in an adolescent girl with blepharophimosis/ptosis/epicanthus inversus syndrome Eur. J. Endocrinol., September 1, 2005; 153(3): 353 - 358. [Abstract] [Full Text] [PDF]

				C. K. Welt, A. Falorni, A. E. Taylor, K. A. Martin, and J. E. Hall Selective Theca Cell Dysfunction in Autoimmune Oophoritis Results in Multifollicular Development, Decreased Estradiol, and Elevated Inhibin B Levels J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3069 - 3076. [Abstract] [Full Text] [PDF]

				A. Bachelot, G. Meduri, N. Massin, M. Misrahi, F. Kuttenn, and P. Touraine Ovarian Steroidogenesis and Serum Androgen Levels in Patients with Premature Ovarian Failure J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2391 - 2396. [Abstract] [Full Text] [PDF]

				C. K. Welt, J. E. Hall, J. M. Adams, and A. E. Taylor Relationship of Estradiol and Inhibin to the Follicle-Stimulating Hormone Variability in Hypergonadotropic Hypogonadism or Premature Ovarian Failure J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 826 - 830. [Abstract] [Full Text] [PDF]

				S. N. Kalantaridou, K. K. Naka, E. Papanikolaou, N. Kazakos, M. Kravariti, K. A. Calis, E. A. Paraskevaidis, D. A. Sideris, A. Tsatsoulis, G. P. Chrousos, et al. Impaired Endothelial Function in Young Women with Premature Ovarian Failure: Normalization with Hormone Therapy J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3907 - 3913. [Abstract] [Full Text] [PDF]

				C. J. Jorgez, M. Klysik, S. P. Jamin, R. R. Behringer, and M. M. Matzuk Granulosa Cell-Specific Inactivation of Follistatin Causes Female Fertility Defects Mol. Endocrinol., April 1, 2004; 18(4): 953 - 967. [Abstract] [Full Text] [PDF]

				N. H. Alzubaidi, H. L. Chapin, V. H. Vanderhoof, K. A. Calis, and L. M. Nelson Meeting the Needs of Young Women With Secondary Amenorrhea and Spontaneous Premature Ovarian Failure Obstet. Gynecol., May 1, 2002; 99(5): 720 - 725. [Abstract] [Full Text] [PDF]

				L. M. Nelson Autoimmune Ovarian Failure: Comparing the Mouse Model and the Human Disease Reproductive Sciences, January 1, 2001; 8(1_suppl): S55 - S57. [Abstract] [PDF]

				K. Rosene-Montella, E. Keely, S. A. Laifer, and R. V. Lee Evaluation and Management of Infertility in Women: The Internists' Role Ann Intern Med, June 20, 2000; 132(12): 973 - 981. [Abstract] [Full Text] [PDF]

				S.N. Kalantaridou, D.T. Braddock, N.J. Patronas, and L.M. Nelson Treatment of autoimmune premature ovarian failure: Case report Hum. Reprod., July 1, 1999; 14(7): 1777 - 1782. [Abstract] [Full Text] [PDF]

				B. Ishizuka, Y. Kudo, A. Amemiya, H. Yamada, T. Matsuda, and T. Ogata Anti-nuclear antibodies in patients with premature ovarian failure Hum. Reprod., January 1, 1999; 14(1): 70 - 75. [Abstract] [Full Text] [PDF]

				A. Hoek, J. Schoemaker, and H. A. Drexhage Premature Ovarian Failure and Ovarian Autoimmunity Endocr. Rev., February 1, 1997; 18(1): 107 - 134. [Abstract] [Full Text]